Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8
Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8
花旗集團以買入評級啓動對Alpha Tau Medical的保險，宣佈目標股價爲8美元
Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price Target of $8.
花旗集團分析師阿希克·穆巴拉克以買入評級開始對Alpha Tau Medical（納斯達克股票代碼：DRTS）進行報道，並宣佈目標股價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。